Core Laboratories EBITDA

CLB
 Stock
  

USD 18.07  0.85  4.49%   

Core Laboratories NV fundamentals help investors to digest information that contributes to Core Laboratories' financial success or failures. It also enables traders to predict the movement of Core Laboratories Stock. The fundamental analysis module provides a way to measure Core Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Core Laboratories stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Core Laboratories EBITDA Margin is projected to slightly decrease based on the last few years of reporting. The past year's EBITDA Margin was at 0.14. The current year Earnings Before Interest Taxes and Depreciation Amortization EBITDA is expected to grow to about 65 M, whereas Enterprise Value over EBITDA is forecasted to decline to 18.93.

Core Laboratories EBITDA Analysis

Core Laboratories' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Core Laboratories Earnings Before Interest Taxes and Depreciation Amortization EBITDA

64.95 Million

EBITDA 
 = 
Revenue 
-  
Basic Expenses 
More About EBITDA | All Equity Analysis

Current Core Laboratories EBITDA

    
  63.29 M  
Most of Core Laboratories' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Core Laboratories NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Core Laboratories EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Core Laboratories is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as EBITDA. Since Core Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Core Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Core Laboratories' interrelated accounts and indicators.

Core Laboratories EBITDA Historical Pattern

Today, most investors in Core Laboratories Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Core Laboratories' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Core Laboratories ebitda as a starting point in their analysis.
   Core Laboratories EBITDA   
Share
       Timeline  
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Compare to competition

Core Laboratories EBITDA Margin

EBITDA Margin

0.16

Core Laboratories EBITDA Margin is projected to slightly decrease based on the last few years of reporting. The past year's EBITDA Margin was at 0.14
According to the company disclosure, Core Laboratories NV reported earnings before interest,tax, depreciation and amortization of 63.29 M. This is 98.94% lower than that of the Energy Equipment & Services sector and 86.89% lower than that of the Energy industry. The ebitda for all United States stocks is 98.38% higher than that of the company.

Core Laboratories EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Core Laboratories' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Core Laboratories could also be used in its relative valuation, which is a method of valuing Core Laboratories by comparing valuation metrics of similar companies.
Core Laboratories is currently under evaluation in ebitda category among related companies.

Core Laboratories Current Valuation Drivers

We derive many important indicators used in calculating different scores of Core Laboratories from analyzing Core Laboratories' financial statements. These drivers represent accounts that assess Core Laboratories' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Core Laboratories' important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Average Assets582.93 M629.33 M783.91 M605.11 M587.5 M674.84 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA136.63 M141.39 M126.99 M(56.5 M)63.29 M64.95 M
Earnings Before Interest Taxes and Depreciation Amortization USD136.63 M141.39 M126.99 M(56.5 M)63.29 M64.95 M
Earnings before Tax101.37 M104.97 M89.69 M(91.74 M)35.62 M36.56 M
Average Equity147.78 M153.9 M184.88 M66.74 M151.23 M138.05 M
Enterprise Value5.06 B2.92 B2.03 B1.5 B1.27 B1.3 B
Free Cash Flow105.82 M89.78 M67.97 M47.22 M23.4 M24.02 M
Invested Capital508.38 M590.47 M802.9 M683.97 M615.05 M677.71 M
Invested Capital Average507.54 M568.48 M791.85 M711.4 M630.07 M676.48 M
Market Capitalization4.84 B2.64 B1.67 B1.18 B1.03 B1.06 B
Tangible Asset Value396.37 M416.36 M543.8 M460.55 M473.27 M512.29 M
Working Capital106.85 M128.43 M109.64 M76.1 M98.27 M103.68 M

Core Laboratories Institutional Holders

Institutional Holdings refers to the ownership stake in Core Laboratories that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Core Laboratories' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Core Laboratories' value.
Security TypeSharesValue
Zurcher Kantonalbank Zurich CantonalbankCommon Shares6.5 K88 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares6.5 K129 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares6.5 K206 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares6.5 K145 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares4.4 K122 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares4.4 K172 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares4.4 K127 K

Core Laboratories Fundamentals

About Core Laboratories Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Core Laboratories NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Core Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Core Laboratories NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
EBITDA Margin 0.14  0.16 
Enterprise Value over EBITDA 20.04  18.93 
Earnings Before Interest Taxes and Depreciation Amortization EBITDA63.3 M65 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in Core Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run CEO Directory Now

   

CEO Directory

Screen CEOs from public companies around the world
All  Next Launch Module

Pair Trading with Core Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Core Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Core Laboratories will appreciate offsetting losses from the drop in the long position's value.

Moving together with Core Laboratories

+0.97WHDCactus Inc Downward RallyPairCorr
+0.9XPROExpro Group Holdings Downward RallyPairCorr
+0.66PHXPHX Minerals Earnings Call This WeekPairCorr

Moving against Core Laboratories

-0.7PHVSPharvaris BV TrendingPairCorr
-0.67MINDMind Technology Earnings Call This WeekPairCorr
The ability to find closely correlated positions to Core Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Core Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Core Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Core Laboratories NV to buy it.
The correlation of Core Laboratories is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Core Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Core Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Core Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Core Laboratories Piotroski F Score and Core Laboratories Altman Z Score analysis. You can also try Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for analysis

When running Core Laboratories price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core Laboratories will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
7.474
Market Capitalization
877.3 M
Quarterly Revenue Growth YOY
0.068
Return On Assets
0.044
Return On Equity
0.0915
The market value of Core Laboratories is measured differently than its book value, which is the value of Core Laboratories that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Core Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.